Replies to post #81002 on $heff's $tation of $tocks & $olid DD

[mulletman99]

$FPMI - Agree. I work in biotech myself, and its been a long time since I have been this excited about a company I am invested in.

The market has NO IDEA how to valuate this company. But.....it will soon enough.

2 products, 1 finishing phase2 and another entering phase2, with market potential of $500mil/yr each (conservative estimate).
- Very low safety risk since as the CEO said, they are injecting micrograms of material (1 millionth of a gram) and the industry does not see safety risks at this level.
- Increases accuracy of diagnosis from 70% with current care to 85% (reduced costs for hospitals/insurance cos.)
- The PET machines already exist - no capital investment needed by hospitals/clinics (current utilization of PET scanners of 40%)
- The software already exists - again no need for capital investment.

This company is a diamond in the rough......take advantage of it.